New Medicaid Bulletin - Continuous Glucose Monitoring Systems Coverage Transition

Effective July 1, 2020, coverage of therapeutic Continuous Glucose Monitoring products will transition from the Durable Medical Equipment Program to the Outpatient Pharmacy Point of Sale Program. Details may be found in the Medicaid Bulletin titled Continuous Glucose Monitoring Systems Coverage Transition, which is now available.

All Medicaid Bulletin articles, including those related to COVID-19, may be found on the DHB website.